Results 261 to 270 of about 104,235 (402)
Primary (AL) Amyloidosis Following COVID‐19 Infection: A Case Report
ABSTRACT Primary (AL) amyloidosis is a rare systemic disorder caused by extracellular deposition of monoclonal immunoglobulin light chains, resulting in multi‐organ dysfunction. SARS‐CoV‐2 infection may induce persistent inflammatory and immune dysregulation, potentially promoting amyloid formation, although clinical evidence is limited, making the ...
Nasrin Gholami +4 more
wiley +1 more source
Alpinumisoflavone ameliorates experimental acute reflux esophagitis in rats via regulation of inflammatory pathway. [PDF]
Zhaorigetu, Ge Z, Zhang W.
europepmc +1 more source
Optimizing radiation dose and fractionation for the definitive treatment of locally advanced non-small cell lung cancer [PDF]
Bradley, Jeffrey D +2 more
core +1 more source
DUPILUMAB: A NEW ALLY FOR THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS?
Lara Zaccarelli Rubira +2 more
openalex +2 more sources
ABSTRACT To characterize the relationship between cendakimab exposure and the longitudinal efficacy endpoint dysphagia days (DD), E–R analyses were performed using data from the EE‐001 study (N = 427) with eosinophilic esophagitis. DD—a bounded, discrete endpoint assessed over 14‐day period via modified daily symptom diary (mDSD)—was modeled using a ...
Shengnan Du +7 more
wiley +1 more source
Comparative Efficacy of Potassium-Competitive Acid Blockers (P-CABs) Versus Proton Pump Inhibitors (PPIs) in the Management of Erosive Esophagitis: A Systematic Review. [PDF]
Raza H +8 more
europepmc +1 more source
Eosinophilic esophagitis: diagnostic tests and criteria
Evan S. Dellon
openalex +1 more source

